- The trend backdrop is active with a 19-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
MERK
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Merck Tbk · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
3,960 IDR
4.2%
latest week
Weekly setup
Constructive trend
The weekly trend is active. Price is 13.5% above the Trend Line and sits at 85.0% of its 52-week range. The latest completed week returned 4.2%, after a 5.9% four-week move. The latest news-sentiment score is 50/100.
Setup score
69
out of 100
Latest Close
3,960 IDR
7 Aug 2026
1W Return
4.2%
latest completed week
4W Return
5.9%
short-term follow-through
12W Return
2.2%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.2%
Latest completed week; four-week move 5.9%.
Indicator stack
79/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.5% above the Trend Line and sits at 85.0% of its 52-week range. The latest completed week returned 4.2%, after a 5.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8212-week average 0.85
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.9% over four weeks, 2.2% over 12 weeks, and 38.9% over one year. The current trend has remained active for 19 consecutive weeks.
Performance by holding period
Active trend streak19 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.19Latest activity-pressure read.
Pressure change234.8%Four-week change in activity pressure.
Leadership38.13Latest relative-leadership reading.
RS change-19.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.2%Distance below the 52-week high.
13-week volatility3.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+12.9%Week of 1 May.
Worst week-5.0%Week of 31 Jul.
Latest week+4.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains10
Flat weeks0
Modest losses12
Sharp losses1
Recent vol3.1%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split26/23Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -1.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank18 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Drug Manufacturers - Specialty & Generic
4-week rank2 / 4
Group average5.5%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS75.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape71/100
Trend, activity pressure, participation, and risk combine to a 71/100 tape read.
Indicator analysis84/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.82; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Enterprise value to EBIT forward of PT Merck Tbk – IDX:MERK Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3,960 IDR | 4.2% | 3,490 IDR | 3,458 IDR | 0.19 | 38.13 | 190.3K | On |
| 31 Jul 2026 | 3,800 IDR | -5.0% | 3,469 IDR | 3,460 IDR | 0.19 | 37.66 | 572.7K | On |
| 24 Jul 2026 | 4,000 IDR | 3.6% | 3,452 IDR | 3,462 IDR | 0.19 | 47.26 | 221.3K | On |
| 17 Jul 2026 | 3,860 IDR | 3.2% | 3,429 IDR | 3,464 IDR | 0.08 | 44.24 | 144.7K | On |
| 10 Jul 2026 | 3,740 IDR | 0.5% | 3,410 IDR | 3,466 IDR | 0.06 | 47.14 | 165.7K | On |
| 3 Jul 2026 | 3,720 IDR | 3.6% | 3,393 IDR | 3,468 IDR | 0.09 | 49.01 | 18.1K | On |
| 26 Jun 2026 | 3,590 IDR | -1.1% | 3,376 IDR | 3,470 IDR | 0.20 | 44.60 | 8.3K | On |
| 19 Jun 2026 | 3,630 IDR | 3.7% | 3,362 IDR | 3,474 IDR | 0.34 | 40.66 | 5.8K | On |
| 12 Jun 2026 | 3,500 IDR | -2.4% | 3,343 IDR | 3,477 IDR | 0.52 | 40.20 | 90.0K | On |
| 5 Jun 2026 | 3,585 IDR | -1.0% | 3,329 IDR | 3,481 IDR | 0.79 | 54.96 | 313.0K | On |
| 29 May 2026 | 3,622 IDR | -3.5% | 3,313 IDR | 3,484 IDR | 1.10 | 44.00 | 148.9K | On |
| 22 May 2026 | 3,752 IDR | -3.1% | 3,288 IDR | 3,488 IDR | 1.38 | 49.11 | 205.3K | On |
| 15 May 2026 | 3,873 IDR | -2.3% | 3,258 IDR | 3,490 IDR | 1.35 | 41.97 | 227.7K | On |
| 8 May 2026 | 3,966 IDR | 1.7% | 3,222 IDR | 3,491 IDR | 1.18 | 40.87 | 683.3K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.